Aspira Women's Health Inc.
AWHL· OTC
Released Nov 10, 2021, after the close
10-Q filed Nov 10, 2021, 41 days after period end · 0000926617-21-000079
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $1.67M | $1.24M | $1.29M | $774.00K |
| Net Income | -$9.71M | -$4.29M | -$3.82M | -$2.65M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.04 |
| -$0.04 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.